One other possibility is that if they (the R/P Group) lost
One other possibility is that if they (the R/P Group) lost in the Delaware court and then appealed and somehow won on appeal, is that notwithstanding that IMHO the shareholder vote would already have occurred without them, the Delaware court would merely order a new vote to occur at that point. This would benefit current management because if the R/P Group lost in the lower court and the vote went on without them, obviously the management would win. Management would have additional time prior to the court of appeal ruling on the matter to have some favorable results, probably ensuring that they would win on a revote if anything good happened in the interim. On the other hand, if the R/P Group won on appeal, and a revote was held, and management had closed nothing in the interim, who knows who people would vote for at that point, notwithstanding the extreme negatives of this current R/P Group. But, currently it would appear that the R/P Group will be between a rock and a hard place if they lose the lower court case on October 6.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...
Continue Reading
Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...
Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...
Continue Reading
Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...
Continue Reading
Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...
Continue Reading
